• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Increased neurodegenerative pathology associated with chronic traumatic encephalopathy severity

byDaniel FisherandMichael Milligan
July 28, 2017
in Chronic Disease, Imaging and Intervention, Neurology, Psychiatry, Public Health
Reading Time: 3 mins read
Epileptogenic foci may be lateralized using functional brain glutamate imaging
Share on FacebookShare on TwitterShare on LinkedIn

1. In this retrospective study of post-mortem tissue from former American football players, pathological markers of neurodegeneration were frequent in both mild and severe chronic traumatic encephalopathy (CTE) cases but not in those without symptomatic CTE.

2. Increased distributions and quantities of neuropathological markers were associated with increasing CTE severity and broader symptoms.

Evidence Rating Level: 3 (Average)

Study Rundown: Repeated mild traumatic brain injury often leads to a heterogeneous disorder known as chronic traumatic encephalopathy (CTE), typified by a progressive neurodegenerative disease affecting mood, cognition, and motor deficits. In particular, professional American football players are at very high risk of developing this disease, though little is known about the underlying neuropathological mechanisms. In this retrospective study of post-mortem tissue from former American football players, common neuropathological markers of neurodegenerative disease, such as a p-tau, pTDP43, a-synuclein, and amyloid-b aggregations, were highly prevalent and increased with CTE severity. The distribution of these markers in mild CTE were mostly restricted to select cortical areas whereas those with more severe CTE demonstrated multiple cortical and subcortical areas of pathology. Of the 17% of post-mortem tissues without CTE, neuropathology was rare and generally non-specific, and most of these tissues were derived from players who did not reach the professional level. Retrospective, secondary clinical information from standardized informant reports suggest that all CTE cases determined pathologically resulted in mood or cognitive symptoms regardless of disease severity. Motor impairment was apparent in over half of severe CTE patients, and development of both mood and cognitive symptoms was typical as the disease progressed. The most common primary cause of death was neurodegeneration in this cohort.

Though this study suggests a high degree of specific neuropathologies in CTE cases, numerous limitations should be noted. First, lack of a standardized control cohorts makes interpreting the degree neuropathology difficult, and few conclusions should be drawn about impact of these biomarkers on CTE symptoms. Second, the degree of head-trauma could not be calculated, though time spent playing football generally correlated with disease severity, though no strictly quantitative measure was reported. Third, as clinical reports were given second hand, the reliability of these reports is unlikely to be as strong and may overestimate the development of certain symptoms. As this project continues to collect tissue, it will be important to note future results from more controlled studies.

Click to read the study, published in JAMA

RELATED REPORTS

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

2 Minute Medicine Rewind Aug 24th, 2026 

Relevant Reading: The spectrum of disease in chronic traumatic encephalopathy

In-Depth [retrospective cohort]: 202 former American football players donated post-mortem tissue to the Concussion Legacy Foundation (CLF) and clinical data from secondary sources were compiled into a Federal Interagency Traumatic Brain Injury Research-compliant database. Of the participants, 0% of those with only pre-high school experience developed CTE (0/2 players), 21% with high-school experience (3/14), 91% with college experience (48/53), 64% of semiprofessional (9/14), 88% with Canadian Football League experience (7/8), and 99% with NFL experience (110/111). The median age for those with mild CTE was 44 years (IQR 29-64 years), and the median age for those with severe CTE was 71 years (IQR 64-79 years). The most common cause of death in mild CTE cases was suicide (27%), while the most common cause of death in severe CTE cases was neurodegenerative (47%). Cortical perivascular tau inclusions were detected in all CTE cases mainly in distinct frontal cortical areas with some deposition in the lateral temporal and inferior parietal. By contrast, those with severe CTE also had multiple inclusions in the medial temporal lobe, including in most limbic structures, as well as certain subcortical areas, such as the basal ganglia and thalamus. TDP43 and a-synuclein were common in all CTE cases, while only severe CTE cases tended to have noticeable amyloid-b plaques and angiopathy. Of the 25 participants (17%) without CTE, 9 had no pathology, 7 had nonspecific findings of hemosiderin-laden macrophages or axonal injury, 4 had vascular pathology, 3 had unspecified tauopathy inconsistent with CTE, 2 had Alzheimer’s Disease, 1 had argyrophillic brain disease, and 1 with Lewy Body Disease. Mood symptoms occurred in 96% of mild cases and 89% of severe cases, while cognitive symptoms manifested in 85% of mild and 95% of severe cases. No CTE cases were symptomatic, and 75% of those with severe CTE developed motor impairments.

 

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic traumatic encephalopathyfootballhead traumaneurocognition
Previous Post

Tocilizumab improves remission rates in giant-cell arteritis: The GiACTA trial

Next Post

Reduction in vaccination rates predicted to increase incidence and cost of measles

RelatedReports

Brain health collage: an engraved brain in side view, a branching neuron, a plain brain-slice silhouette and a reflex hammer
Chronic Disease

One in four National Football League (NFL) players who died between 2016-2021 had evidence of chronic traumatic encephalopathy

August 27, 2026
Surgical outcomes collage: an operating lamp above a steel tray of scalpel, forceps and scissors beside a folded drape
Weekly Rewinds

2 Minute Medicine Rewind Aug 24th, 2026 

August 26, 2026
Obstetric scoring systems overestimate cases of severe sepsis
Infectious Disease

Propofol is associated with lower mortality in sepsis-associated encephalopathy

February 11, 2026
Eye disease collage: a close-up of one eye, round wire-rimmed glasses, an ophthalmoscope and a cross-section of the eyeball
Chronic Disease

No difference between pharmacologic treatments in age-related macular degeneration risk reduction

May 8, 2025
Next Post

Reduction in vaccination rates predicted to increase incidence and cost of measles

Genetic variants related to serum calcium levels associated with coronary artery disease

Half of all readmissions following lower respiratory infections occur in infants

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • In topline phase 3 results, nomelcitinib improved PASI 90 and PGA 0/1 responses versus placebo in plaque psoriasis
  • Intraosseous cefuroxime (Ceftin) may improve tissue delivery compared to intravenous administration during total knee arthroplasty
  • 2 Minute Medicine Rewind November 2, 2026
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.